Crossref
MASH as a network disease: therapeutic modulation of interorgan immunometabolic architecture
Metabolism and Target Organ Damage · 16.07.2026 · 6 (3)
DOI: 10.20517/mtod.2026.54 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 16.07.2026. Verfasst von Javier Crespo und 2 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Crespo, J., Jiménez-González, C., & Iruzubieta, P. (2026). MASH as a network disease: therapeutic modulation of interorgan immunometabolic architecture. Metabolism and Target Organ Damage, 6(3). https://doi.org/10.20517/mtod.2026.54
Vancouver
Crespo J, Jiménez-González C, Iruzubieta P. MASH as a network disease: therapeutic modulation of interorgan immunometabolic architecture. Metabolism and Target Organ Damage. 2026;6(3). doi:10.20517/mtod.2026.54
BibTeX
@article{Crespo2026,
author = {Crespo, Javier and Jiménez-González, Carolina and Iruzubieta, Paula},
title = {MASH as a network disease: therapeutic modulation of interorgan immunometabolic architecture},
journal = {Metabolism and Target Organ Damage},
year = {2026},
volume = {6},
number = {3},
doi = {10.20517/mtod.2026.54}
}
EUVIMED